Adar1 Capital Management, LLC Cytokinetics Inc Transaction History
Adar1 Capital Management, LLC
- $441 Billion
- Q1 2024
A detailed history of Adar1 Capital Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 319,510 shares of CYTK stock, worth $18 Million. This represents 5.08% of its overall portfolio holdings.
Number of Shares
319,510
Previous 92,082
246.98%
Holding current value
$18 Million
Previous $7.69 Billion
191.38%
% of portfolio
5.08%
Previous 2.75%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
461Shares Held
107MCall Options Held
7.2MPut Options Held
6.2M-
Black Rock Inc. New York, NY12.4MShares$700 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$564 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$289 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$270 Million0.03% of portfolio
-
State Street Corp Boston, MA4.52MShares$255 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.31B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...